SPRY R&D Expenses
Ars Pharmaceuticals Inc · R&D Expenses
SPRY R&D Expenses
Latest reported$4.70Mperiod ending
SPRY Quarterly R&D Expenses ($6.27M → $4.70M)
Quarterly R&D Expenses
High-resolution chart · PNG
SPRY r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,698,000 | |
| 4,336,000 | |
| 3,443,000 | |
| 2,751,000 | |
| 4,035,000 | |
| 2,952,000 | |
| 3,027,000 | |
| 4,423,000 | |
| 6,896,000 | |
| 5,234,000 | |
| 3,404,000 | |
| 3,002,000 | |
| 7,308,000 | |
| 6,552,000 | |
| 4,710,000 | |
| 3,893,000 | |
| 4,350,000 | |
| 5,423,000 | |
| 3,914,000 | |
| 5,122,000 | |
| 5,618,500 | |
| 5,618,500 | |
| 8,648,000 | |
| 4,988,000 | |
| 4,275,000 | |
| 6,273,000 |